NeuroVascular Quality Initiative® expands with new Cerebral Aneurysm and Cerebral AVMs modules

NeuroVascular Quality Initiative® expands with new Cerebral Aneurysm and Cerebral AVMs modules


The Society of NeuroInterventional Surgery® (SNIS) and M2S®, a leading clinical registry provider, are pleased to announce the launch of the new Cerebral Aneurysm module for the NeuroVascular Quality Initiative (NVQI®), and the planned launch for the Cerebral Arteriovenous Malformations (AVMs) module in early October. The development of these web-based quality modules significantly broadens the scope of NVQI, and, together with the existing Acute Ischemic Stroke module, will provide new insights into outcomes and the efficacy of different NeuroInterventional therapies. The NVQI is the first clinical registry to focus exclusively on all aspects of neurovascular care.

The NVQI has already enrolled several facilities across five states and captured over 120 procedures. Additional contracts are in process for all three modules. Some of the current participating centers include the Cleveland Clinic, Erlanger Medical Center, Cadence Health Central DuPage Hospital, Novant-Forsyth Medical Center and Baylor University Medical Center at Dallas. Future NVQI modules are planned for 2016.

“To drive the quality improvements essential for our profession and for our patients, we need detailed outcomes data that only a registry designed for NeuroInterventional procedures can provide for us. The NVQI will be instrumental in building greater understanding of different patient populations and best practices as we start to tap into this valuable data source,” said Charles J. Prestigiacomo, MD, Medical Director of the SNIS Patient Safety Organization.

The NVQI has been designed to track key outcomes to demonstrate areas for clinical improvement. NVQI centers can compare processes, complication rates, and length of stay as well as medical device effectiveness. Specifically, NVQI is designed to support individual neurointerventionalists and hospitals by driving better understanding of outcomes and developing best practice in neurovascular surgery.

M2S has been working with the SNIS as their registry technology partner, and hosts the NVQI. All data are securely stored within the M2S PATHWAYS quality improvement data platform. All three NVQI modules track and measure individual procedures, as well as benchmark variation among different physicians and different centers and provide drill-down capabilities.

Betti Kerrigan, VP of Sales and Marketing for M2S, adds, “Use of M2S PATHWAYS will allow NVQI members to collect and analyze procedure data in greater detail, in real time. Together, PATHWAYS and NVQI can help hospitals and clinicians track neurovascular outcomes so they can drive quality and reduce costs.”

For M2S Inquiries:
Betti Kerrigan
VP of Sales and Marketing
T: 603.298.5509
For SNIS Inquiries:
Marie Williams, CAE
Executive Director
T: 703-691-2272

The Society of NeuroInterventional Surgery (SNIS)

The Society of NeuroInterventional Surgery (SNIS) is a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery through research, standard-setting education and advocacy in order to provide the highest quality of patient care in diagnosing and treating diseases of the brain, spine, head and neck. Follow us on Twitter @SNISinfo.


M2S Inc.

M2S provides technology and services to the healthcare industry to manage clinical information, reduce costs, and improve the quality of patient care. Our extensive experience in medical imaging, data management, and outcomes analysis has positioned us as the leader in providing cost-effective, innovative healthcare performance management solutions to our customers. Through our M2S PATHWAYS clinical data performance platform, we provide comprehensive tools for clinical data management, clinical outcomes assessment, and research needs. This secure, cloud-based solution enables physicians, institutions, and researchers to collect, manage, analyze, and disseminate their clinical data to achieve optimal outcomes. For more information, see